organization · Reporting owner
BOSTON SCIENTIFIC CORP
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Pulmonx CorpLUNG · Entity 2359 | 10% owner | July 13, 2021 | July 14, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Pulmonx Corp
Report date July 13, 2021 · Filed July 14, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,488,106 |
Reported balance
After 2021-07-13 transaction · row 1
1 source rowRow 1 · 2021-07-13 · Sale · Disposed 2,500,000 · Balance 1,488,106 F1: These shares of the Issuer's common stock were sold in a block order at a price of $37.45. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares of the Issuer's common stock were sold in a block order at a price of $37.45.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 13, 2021 Filed Jul 14, 2021 20:10 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 2,500,000 | $37.45 | $93,625,000.00 |
DisclosureSEC source: 0001225208-21-010646 · doc4.xml · nonDerivative · entry 1 BOSTON SCIENTIFIC CORP · CIK 0000885725 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,488,106 F1 · kind: These shares of the Issuer's common stock were sold in a block order at a price of $37.45. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 20:20 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 650,000 | $43.60 | $28,340,000.00 |
DisclosureSEC source: 0001225208-21-006650 · doc4.xml · nonDerivative · entry 1 BOSTON SCIENTIFIC CORP · CIK 0000885725 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,988,106 F1 · kind: These shares of the Issuer's common stock were sold in a block order at a price of $43.60. Read SEC document |
| March 30, 2021 Filed Apr 1, 2021 20:24 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 1,350,000 | $40.80 | $55,080,000.00 |
DisclosureSEC source: 0001225208-21-006217 · doc4.xml · nonDerivative · entry 1 BOSTON SCIENTIFIC CORP · CIK 0000885725 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,638,106 F1 · kind: These shares of the Issuer's common stock were sold in a block order at a price of $40.80. Read SEC document |
| October 05, 2020 Filed Oct 5, 2020 22:46 UTC | Pulmonx Corp LUNG · Entity 2359 | ConversionSeries G-1 Preferred Stock · Derivative | 2,081,909 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-012257 · doc4.xml · derivative · entry 14 BOSTON SCIENTIFIC CORP · CIK 0000885725 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,081,909 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Issuer's preferred stock automatically converted into an equal number of shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date. F1 · derivative.exercise_date: The Issuer's preferred stock automatically converted into an equal number of shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date. F1 · derivative.expiration_date: The Issuer's preferred stock automatically converted into an equal number of shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date. Read SEC document |
| October 05, 2020 Filed Oct 5, 2020 22:46 UTC | Pulmonx Corp LUNG · Entity 2359 | ConversionSeries F-1 Preferred Stock · Derivative | 3,787,878 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-012257 · doc4.xml · derivative · entry 13 BOSTON SCIENTIFIC CORP · CIK 0000885725 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,787,878 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Issuer's preferred stock automatically converted into an equal number of shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date. F1 · derivative.exercise_date: The Issuer's preferred stock automatically converted into an equal number of shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date. F1 · derivative.expiration_date: The Issuer's preferred stock automatically converted into an equal number of shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date. Read SEC document |
| October 05, 2020 Filed Oct 5, 2020 22:46 UTC | Pulmonx Corp LUNG · Entity 2359 | ConversionSeries E-1 Preferred Stock · Derivative | 6,215 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-012257 · doc4.xml · derivative · entry 12 BOSTON SCIENTIFIC CORP · CIK 0000885725 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,215 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Issuer's preferred stock automatically converted into an equal number of shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date. F1 · derivative.exercise_date: The Issuer's preferred stock automatically converted into an equal number of shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date. F1 · derivative.expiration_date: The Issuer's preferred stock automatically converted into an equal number of shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date. Read SEC document |
| October 05, 2020 Filed Oct 5, 2020 22:46 UTC | Pulmonx Corp LUNG · Entity 2359 | ConversionSeries D-1 Preferred Stock · Derivative | 542 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-012257 · doc4.xml · derivative · entry 11 BOSTON SCIENTIFIC CORP · CIK 0000885725 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 542 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Issuer's preferred stock automatically converted into an equal number of shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date. F1 · derivative.exercise_date: The Issuer's preferred stock automatically converted into an equal number of shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date. F1 · derivative.expiration_date: The Issuer's preferred stock automatically converted into an equal number of shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date. Read SEC document |
| October 05, 2020 Filed Oct 5, 2020 22:46 UTC | Pulmonx Corp LUNG · Entity 2359 | ConversionSeries C-1 Preferred Stock · Derivative | 23,180 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-012257 · doc4.xml · derivative · entry 10 BOSTON SCIENTIFIC CORP · CIK 0000885725 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,180 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Issuer's preferred stock automatically converted into an equal number of shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date. F1 · derivative.exercise_date: The Issuer's preferred stock automatically converted into an equal number of shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date. F1 · derivative.expiration_date: The Issuer's preferred stock automatically converted into an equal number of shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date. Read SEC document |
| October 05, 2020 Filed Oct 5, 2020 22:46 UTC | Pulmonx Corp LUNG · Entity 2359 | ConversionSeries B-1 Preferred Stock · Derivative | 47,536 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-012257 · doc4.xml · derivative · entry 9 BOSTON SCIENTIFIC CORP · CIK 0000885725 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 47,536 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Issuer's preferred stock automatically converted into an equal number of shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date. F1 · derivative.exercise_date: The Issuer's preferred stock automatically converted into an equal number of shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date. F1 · derivative.expiration_date: The Issuer's preferred stock automatically converted into an equal number of shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date. Read SEC document |
| October 05, 2020 Filed Oct 5, 2020 22:46 UTC | Pulmonx Corp LUNG · Entity 2359 | ConversionSeries A-1 Preferred Stock · Derivative | 40,705 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-012257 · doc4.xml · derivative · entry 8 BOSTON SCIENTIFIC CORP · CIK 0000885725 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,705 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Issuer's preferred stock automatically converted into an equal number of shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date. F1 · derivative.exercise_date: The Issuer's preferred stock automatically converted into an equal number of shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date. F1 · derivative.expiration_date: The Issuer's preferred stock automatically converted into an equal number of shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date. Read SEC document |
| October 05, 2020 Filed Oct 5, 2020 22:46 UTC | Pulmonx Corp LUNG · Entity 2359 | ConversionCommon Stock | 542 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-012257 · doc4.xml · nonDerivative · entry 7 BOSTON SCIENTIFIC CORP · CIK 0000885725 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,988,106 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Issuer's preferred stock automatically converted into an equal number of shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date. Read SEC document |
| October 05, 2020 Filed Oct 5, 2020 22:46 UTC | Pulmonx Corp LUNG · Entity 2359 | ConversionCommon Stock | 6,215 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-012257 · doc4.xml · nonDerivative · entry 6 BOSTON SCIENTIFIC CORP · CIK 0000885725 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,987,564 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Issuer's preferred stock automatically converted into an equal number of shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date. Read SEC document |
| October 05, 2020 Filed Oct 5, 2020 22:46 UTC | Pulmonx Corp LUNG · Entity 2359 | ConversionCommon Stock | 23,180 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-012257 · doc4.xml · nonDerivative · entry 5 BOSTON SCIENTIFIC CORP · CIK 0000885725 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,981,349 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Issuer's preferred stock automatically converted into an equal number of shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date. Read SEC document |
| October 05, 2020 Filed Oct 5, 2020 22:46 UTC | Pulmonx Corp LUNG · Entity 2359 | ConversionCommon Stock | 40,705 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-012257 · doc4.xml · nonDerivative · entry 4 BOSTON SCIENTIFIC CORP · CIK 0000885725 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,958,169 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Issuer's preferred stock automatically converted into an equal number of shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date. Read SEC document |
| October 05, 2020 Filed Oct 5, 2020 22:46 UTC | Pulmonx Corp LUNG · Entity 2359 | ConversionCommon Stock | 47,536 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-012257 · doc4.xml · nonDerivative · entry 3 BOSTON SCIENTIFIC CORP · CIK 0000885725 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,917,464 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Issuer's preferred stock automatically converted into an equal number of shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date. Read SEC document |
| October 05, 2020 Filed Oct 5, 2020 22:46 UTC | Pulmonx Corp LUNG · Entity 2359 | ConversionCommon Stock | 2,081,909 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-012257 · doc4.xml · nonDerivative · entry 2 BOSTON SCIENTIFIC CORP · CIK 0000885725 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,869,928 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Issuer's preferred stock automatically converted into an equal number of shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date. Read SEC document |
| October 05, 2020 Filed Oct 5, 2020 22:46 UTC | Pulmonx Corp LUNG · Entity 2359 | ConversionCommon Stock | 3,787,878 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-012257 · doc4.xml · nonDerivative · entry 1 BOSTON SCIENTIFIC CORP · CIK 0000885725 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,788,019 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Issuer's preferred stock automatically converted into an equal number of shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.